查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1404809

臨床試驗設施管理組織市場規模、佔有率和趨勢分析報告：2024-2030 年臨床試驗服務/組件、階段、治療領域、地區和細分市場預測

Clinical Trial Site Management Organizations Market Size, Share & Trends Analysis Report By Clinical Trail Service/Component, By Phase, By Therapeutic Areas (Oncology, Cardiology, CNS), By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 275 Pages | 商品交期: 2-10個工作天內

價格

臨床試驗設施管理組織市場的成長與趨勢：

Grand View Research, Inc. 的最新報告顯示，到 2030 年，全球臨床試驗現場管理組織市場預計將達到 94.7 億美元。

預計2024年至2030年該市場將以6.17%的複合年成長率擴張。臨床實驗管理組織 (SMO) 是製藥和生物製藥公司的重要組成部分。這些組織有助於減輕與臨床研究相關的負擔。 SMO 提供多項服務，包括病患登記服務、特定地點研究活動、僱用研究人員以及監控臨床試驗地點運作。綜合設施網路和臨床試驗服務的全球技術趨勢的改進、臨床服務外包趨勢的增加以及由於慢性病和感染疾病的高負擔而擴大的全球臨床試驗活動正在推動市場。促進因素。

技術可以透過改善臨床實驗識別、選擇和效能等指標，並透過分析臨床實驗招募、註冊、選擇、保留和合規性措施來提高站點層級的效率，從而提高整個患者群體的效率。此外，技術進步增強了生物統計學和資料分析分析，以便在開發階段的階段更好地評估藥物的可行性。由於 COVID-19 大流行，一些組織被迫停止業務，而另一些組織則被迫完全停止業務。然而，SMO有效地進行了多偏心測試，為公司節省了金錢和時間。

手動流程和文書工作將被數位技術取代，以限制疫情對企業的負面影響。因此，SMO 有助於提供詳細的記錄，同時簡化任何臨床研究的步驟，即使身體接觸幾乎不可能阻止病毒的傳播。 SMO 高效的追蹤技能，以及採用虛擬技術進行臨床研究，顯著減少了患者招募所需的時間。隨著世界不同地區發現新病毒，研究仍是重中之重。醫療和生物技術公司可能需要 SMO 來執行資料收集、參與者和病患安全、病患招募、更準確的醫生聯絡資訊和其他任務。因此，這些因素支撐著2021年整體市場收益的復甦。

臨床試驗設施管理組織市場報告亮點

  • 計劃管理細分市場在 2023 年以 25.0% 的銷售佔有率佔據主導地位。這對於確保臨床試驗的設立、入組、按時報告並按預算進行是必要的。
  • 2023年，三期業務的銷售佔有率最大，為54.16%。這種成長是由於 III 期試驗往往規模最大，涉及數千名參與者，而且費用最高。
  • 以治療領域來看，腫瘤學預計在預測期內的複合年成長率將達到 6.66%，是市場上最快的。這是因為全球癌症的高盛行率正在創造對藥物的需求並增加市場佔有率。
  • 預計亞太地區將在 2023 年引領市場，並在預測期內複合年成長率最快，達到 6.87%。因為 SMO 提供的具有成本效益的策略解決方案可以縮短臨床試驗市場變化的時間，快速招募和龐大的患者群是先決條件。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第 3 章：臨床中心管理組織 (SMO) 市場：變數、趨勢和範圍

  • 市場區隔和範圍
  • 市場動態
    • 市場促進因素分析
    • 市場抑制因素分析
  • 普及和成長前景圖
  • COVID-19 對市場的影響
  • 主要交易及策略聯盟分析
  • 臨床試驗現場管理組織 (SMO)：市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析

第4章臨床試驗中心管理組織（SMO）市場：臨床試驗服務/組件細分分析

  • 臨床試驗現場管理組織 (SMO) 市場：定義與範圍
  • 臨床試驗中心管理組織 (SMO)：2023 年和 2030 年市場佔有率分析
  • 現場管理
    • 現場管理市場，2018-2030
  • 計劃管理
    • 計劃管理市場，2018-2030
  • 現場監控
    • 2018-2030年現場監控市場
  • 規定
    • 受監管市場，2018-2030
  • 其他
    • 其他市場，2018-2030

第5章臨床試驗中心管理組織（SMO）市場：階段分析

  • 臨床試驗現場管理組織 (SMO) 市場：定義與範圍
  • 臨床試驗中心管理組織 (SMO)：2023 年和 2030 年市場佔有率分析
  • 第一階段
    • 第一市場，2018-2030
  • 第二階段
    • 二期市場，2018-2030
  • 第三階段
    • 三期市場，2018-2030
  • 第四階段
    • 第四期市場，2018-2030

第6章臨床實驗中心管理組織 (SMO) 市場：治療領域分析

  • 臨床試驗現場管理組織 (SMO) 市場：定義與範圍
  • 臨床試驗中心管理組織 (SMO)：2023 年和 2030 年市場佔有率分析
  • 腫瘤學
    • 腫瘤市場，2018-2030
  • 心臟病學
    • 循環系統市場，2018-2030
  • 中樞神經系統
    • 中樞神經系統市場，2018-2030
  • 疼痛管理
    • 疼痛管理市場，2018-2030
  • 內分泌
    • 內分泌市場，2018-2030
  • 其他
    • 其他市場，2018-2030

第7章 臨床試驗中心管理組織（SMO）市場：區域分析

  • 臨床試驗中心管理組織 (SMO)：市場佔有率分析
  • 北美洲
    • 北美臨床試驗設施管理組織
    • 美國
    • 加拿大
  • 歐洲
    • 歐洲臨床試驗設施管理局
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 亞太臨床試驗設施管理組織
    • 印度
    • 日本
    • 中國
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 拉丁美洲臨床試驗設施管理組織
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東/非洲
    • 中東和非洲的臨床試驗設施管理組織
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章 公司簡介

  • 公司簡介
    • Clinedge
    • WCG
    • ClinChoice
    • Access Clinical Research
    • FOMAT Medical Research INC.
    • SGS
    • KV Clinical
    • SMO-Pharmina
    • Xylem Clinical Research
    • Aurum Clinical Research
Product Code: GVR-4-68039-921-9

Clinical Trials Site Management Organizations Market Growth & Trends:

The global clinical trials site management organizations market size is expected to reach USD 9.47 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 6.17% from 2024 to 2030. Site management organizations (SMOs) are essential elements of pharmaceutical and biopharmaceutical companies. Such organizations help to limit the burden associated with clinical research. SMOs offer several services including patient enrollment services, addressing clinical trial location-specific study activities, hiring study staff, and monitoring clinical studies site operations. Improved technological use in integrated site networks and clinical trial services, increasing trend of outsourced clinical services, and growing clinical trial activities globally owing to the high burden of chronic and infectious diseases, are few of the factors driving the market.

Technology has improved efficiencies at the site level by improving metrics such as on-site identification, selection, and performance, as well as throughout the patient spectrum by analyzing recruitment, enrollment, selection, retention, and compliance measures at sites. Furthermore, technical improvements have resulted in enhanced biostatistics and data analytics analysis to better evaluate a drug's feasibility early in the development phase. As a result of the COVID-19 pandemic, several organizations were forced to halt operations while others were forced to completely shut down. However, the SMOs execute multi-eccentric trials effectively to save the firm money and time.

Manual processes and paperwork are replaced by digital technologies to limit the negative impact of the pandemic on the business. Due to this, Site Management Organization facilitates detailed documentation while also streamlining the procedure in any clinical research, even when physical contact is nearly impossible to prevent viral spread. SMO's efficient follow-up skills along with the adoption of virtual technologies to conduct clinical research have significantly decreased the time required to recruit patients. As new virus strains are being discovered in different areas of the world, research would remain a top focus. SMOs would be required by health and biotech companies for data collection, participant or patient safety, patient recruitment, more accurate doctor contact information, and other tasks. Hence, such factors are supporting the rebound of revenues across the market during 2021.

Clinical Trials Site Management Organizations Market Report Highlights:

  • The project management segment dominated the market with a revenue share of 25.0% in 2023, due to the fact that it is required to ensure that clinical trials are set up, enrolled, reported on time, and conducted within the budget
  • The phase III segment accounted for the largest revenue share of 54.16% in 2023. This growth is attributed to the fact that phase III trials are often the largest and involve thousands of participants and are the most expensive ones
  • Based on therapeutic area, the oncology segment is anticipated to witness the fastest CAGR of 6.66% in the market during the forecast period, due to the high global prevalence of cancer, which is generating demand for drugs and thus increasing its market share
  • Asia Pacific led the market in 2023 and is projected to witness the fastest CAGR of 6.87% during the forecast years, as cost-effective strategic solutions provided by SMOs could reduce timelines, as in changing market for clinical trials, fast recruitment, and a huge pool of patients are some of the prerequisites

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Estimates and Forecast Timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased Database
    • 1.3.2. GVR's Internal Database
    • 1.3.3. Secondary Sources
    • 1.3.4. Primary Research
    • 1.3.5. Details of Primary Research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data Analysis Models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity Flow Analysis (model 1)
    • 1.6.2. Volume Price Analysis (model 2)
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. List of Abbreviations
  • 1.10 Objectives
    • 1.10.1. Objective - 1
    • 1.10.2. Objective - 2
    • 1.10.3. Objective - 3
    • 1.10.4. Objective - 4

Chapter 2 Executive Summary

  • 2.1. Market Outlook

Chapter 3 Clinical Trial Site Management Organizations (SMOs) Market: Variables, Trends, & Scope

  • 3.1. Market Segmentation and Scope
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1 Growth in the number of clinical Studies
      • 3.2.1.2. Rising investment in R&D by the pharmaceutical companies.
      • 3.2.1.3. Increasing rate of clinical trials outsourcing by pharmaceutical and biopharmaceutical companies.
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High cost of clinical studies
      • 3.2.2.2. Presence of significant CROs offering site management services possesses the threat to steal its market share
  • 3.3. Penetration & Growth Prospect Mapping
  • 3.4. COVID-19 Impact on the Market
  • 3.5. Major Deals and Strategic Alliances Analysis
  • 3.6. Clinical Trial Site Management Organizations (SMO)s: Market Analysis Tools
    • 3.6.1. Industry Analysis - Porter's
    • 3.6.2. PESTEL Analysis

Chapter 4 Clinical Trial Site Management Organizations (SMOs) Market: Clinical Trial Services/ Components Segment Analysis

  • 4.1 Clinical Trial Site Management Organizations (SMOs) Market: Definition & Scope
  • 4.2 Clinical Trial Site Management Organizations (SMO): Market Share Analysis, 2023 & 2030
  • 4.3 Site Management
    • 4.3.1 Site Management Market, 2018 - 2030 (USD Million)
  • 4.4 Project Management
    • 4.4.1 Project Management market, 2018 - 2030 (USD Million)
  • 4.5 Onsite Monitoring
    • 4.5.1 Onsite Monitoring market, 2018 - 2030 (USD Million)
  • 4.6 Regulatory
    • 4.6.1 Regulatory Market, 2018 - 2030 (USD Million)
  • 4.7. Others
    • 4.7.1 Others market, 2018 - 2030 (USD Million)

Chapter 5 Clinical Trial Site Management Organizations (SMOs) Market: Phase Analysis

  • 5.1 Clinical Trial Site Management Organizations (SMOs) Market: Definition & Scope
  • 5.2 Clinical Trial Site Management Organizations (SMO) : Market Share Analysis, 2023 & 2030
  • 5.3 Phase I
    • 5.3.1 Phase I Market, 2018 - 2030 (USD Million)
  • 5.4. Phase II
    • 5.4.1 Phase II Market, 2018 - 2030 (USD Million)
  • 5.5 Phase III
    • 5.5.1. Phase III Market, 2018 - 2030 (USD Million)
  • 5.6 Phase IV
    • 5.6.1. Phase IV Market, 2018 - 2030 (USD Million)

Chapter 6 Clinical Trial Site Management Organizations (SMOs) Market: Therapeutic Area Analysis

  • 6.1 Clinical Trial Site Management Organizations (SMOs) Market: Definition & Scope
  • 6.2 Clinical Trial Site Management Organizations (SMO): Market Share Analysis, 2023 & 2030
  • 6.3 Oncology
    • 6.3.1 Oncology Market, 2018 - 2030 (USD Million)
  • 6.4. Cardiology
    • 6.4.1 Cardiology Market, 2018 - 2030 (USD Million)
  • 6.5 CNS
    • 6.5.1. CNS Market, 2018 - 2030 (USD Million)
  • 6.6 Pain Management
    • 6.6.1. Pain Management Market, 2018 - 2030 (USD Million)
  • 6.7 Endocrine
    • 6.7.1. Endocrine Market, 2018 - 2030 (USD Million)
  • 6.8 Others
    • 6.8.1. Others Market, 2018 - 2030 (USD Million)

Chapter 7 Clinical Trial Site Management Organizations (SMOs) Market: Regional Analysis

  • 7.1 Clinical Trial Site Management Organizations (SMO): Market Share Analysis
  • 7.2 North America
    • 7.2.1 North America Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030 (USD Million)
    • 7.2.2 U.S.
      • 7.2.2.1 U.S. Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030 (USD Million)
    • 7.2.3 Canada
      • 7.2.3.1 Canada Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030 (USD Million)
  • 7.3 Europe
    • 7.3.1 Europe Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030 (USD Million)
    • 7.3.2 UK
      • 7.3.2.1 UK Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030 (USD Million)
    • 7.3.3 Germany
      • 7.3.3.1 Germany Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030 (USD Million)
    • 7.3.4 France
      • 7.3.4.1 France Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030 (USD Million)
    • 7.3.5 Italy
      • 7.3.5.1 Italy Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030 (USD Million)
    • 7.3.6 Spain
      • 7.3.6.1 Spain Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030(USD Million)
    • 7.3.7 Denmark
      • 7.3.7.1 Denmark Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030 (USD Million)
    • 7.3.8 Sweden
      • 7.3.8.1 Sweden Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030 (USD Million)
    • 7.3.9 Norway
      • 7.3.9.1 Norway Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030(USD Million)
  • 7.4 Asia Pacific
    • 7.4.1 Asia Pacific Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030 (USD Million)
    • 7.4.2 India
      • 7.4.2.1 India Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030 (USD Million)
    • 7.4.3 Japan
      • 7.4.3.1 Japan Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030 (USD Million)
    • 7.4.4 China
      • 7.4.4.1 China Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030 (USD Million)
    • 7.4.5 Australia
      • 7.4.5.1 Australia Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030 (USD Million)
    • 7.4.6 South Korea
      • 7.4.6.1 South Korea Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030 (USD Million)
    • 7.4.7 Thailand
      • 7.4.7.1 Thailand Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030 (USD Million)
  • 7.5 Latin America
    • 7.5.1 Latin America Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030 (USD Million)
    • 7.5.2 Brazil
      • 7.5.2.1 Brazil Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030 (USD Million)
    • 7.5.3 Mexico
      • 7.5.3.1 Mexico Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030 (USD Million)
    • 7.5.4 Argentina
      • 7.5.4.1 Argentina Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030 (USD Million)
  • 7.6 MEA
    • 7.6.1 MEA Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030 (USD Million)
    • 7.6.2 South Africa
      • 7.6.2.1 South Africa Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030 (USD Million)
    • 7.6.3 Saudi Arabia
      • 7.6.3.1 Saudi Arabia Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030 (USD Million)
    • 7.6.4 UAE
      • 7.6.4.1 UAE Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030 (USD Million)
    • 7.6.5 Kuwait
      • 7.6.5.1 Kuwait Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030 (USD Million)

Chapter 8 Company Profiles

  • 8.1 Company Profiles
    • 8.1.1 Clinedge
      • 8.1.1.1 Company Overview
      • 8.1.1.2 Financial Performance
      • 8.1.1.3 Service Benchmarking
      • 8.1.1.4 Strategic Initiative
    • 8.1.2 WCG
      • 8.1.2.1 Company Overview
      • 8.1.2.2 Financial Performance
      • 8.1.2.3 Service Benchmarking
      • 8.1.2.4 Strategic Initiative
    • 8.1.3 ClinChoice
      • 8.1.3.1 Company Overview
      • 8.1.3.2 Financial Performance
      • 8.1.3.3 Service Benchmarking
      • 8.1.3.4 Strategic Initiatives
    • 8.1.4 Access Clinical Research
      • 8.1.4.1 Company Overview
      • 8.1.4.2 Financial Performance
      • 8.1.4.3 Service Benchmarking
      • 8.1.4.4 Strategic Initiatives
    • 8.1.5 FOMAT Medical Research INC.
      • 8.1.5.1 Company Overview
      • 8.1.5.2 Financial Performance
      • 8.1.5.3 Service Benchmarking
      • 8.1.5.4 Strategic Initiatives
    • 8.1.6 SGS
      • 8.1.6.1 Company Overview
      • 8.1.6.2 Financial Performance
      • 8.1.6.3 Service Benchmarking
      • 8.1.6.4 Strategic Initiatives
    • 8.1.7 KV Clinical
      • 8.1.7.1 Company Overview
      • 8.1.7.2 Financial Performance
      • 8.1.7.3 Service Benchmarking
      • 8.1.7.4 Strategic Initiatives
    • 8.1.8 SMO-Pharmina
      • 8.1.8.1 Company Overview
      • 8.1.8.2 Financial Performance
      • 8.1.8.3 Service Benchmarking
      • 8.1.8.4 Strategic Initiatives
    • 8.1.9 Xylem Clinical Research
      • 8.1.9.1 Company Overview
      • 8.1.9.2 Financial Performance
      • 8.1.9.3 Service Benchmarking
      • 8.1.9.4 Strategic Initiatives
    • 8.1.10 Aurum Clinical Research
      • 8.1.10.1 Company Overview
      • 8.1.10.2 Financial Performance
      • 8.1.10.3 Service Benchmarking
      • 8.1.10.4 Strategic Initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Clinical Trial Site Management Organizations (SMOs) Market, by Services/ Components, 2018 - 2030 (USD Million)
  • Table 4 Global Clinical Trial Site Management Organizations (SMOs) Market, by Phase, 2018 - 2030 (USD Million)
  • Table 5 Global Clinical Trial Site Management Organizations (SMOs) Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
  • Table 6 Global Clinical Trial Site Management Organizations (SMOs) Market, by Region, 2018 - 2030 (USD Million)
  • Table 7 North America Clinical Trial Site Management Organizations (SMOs) Market, by Country, 2018 - 2030 (USD Million)
  • Table 8 North America Clinical Trial Site Management Organizations (SMOs) Market, by Services/ Components, 2018 - 2030 (USD Million)
  • Table 9 North America Clinical Trial Site Management Organizations (SMOs) Market, by Phase, 2018 - 2030 (USD Million)
  • Table 10 North America Clinical Trial Site Management Organizations (SMOs) Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
  • Table 11 US Clinical Trial Site Management Organizations (SMOs) Market, by Services/ Components, 2018 - 2030 (USD Million)
  • Table 12 US Clinical Trial Site Management Organizations (SMOs) Market, by Phase, 2018 - 2030 (USD Million)
  • Table 13 US Clinical Trial Site Management Organizations (SMOs) Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
  • Table 14 Canada Clinical Trial Site Management Organizations (SMOs) Market, by Services/ Components, 2018 - 2030 (USD Million)
  • Table 15 Canada Clinical Trial Site Management Organizations (SMOs) Market, by Phase, 2018 - 2030 (USD Million)
  • Table 16 Canada Clinical Trial Site Management Organizations (SMOs) Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
  • Table 17 Europe Clinical Trial Site Management Organizations (SMOs) Market, by Country, 2018 - 2030 (USD Million)
  • Table 18 Europe Clinical Trial Site Management Organizations (SMOs) Market, by Services/ Components, 2018 - 2030 (USD Million)
  • Table 19 Europe Clinical Trial Site Management Organizations (SMOs) Market, by Phase, 2018 - 2030 (USD Million)
  • Table 20 Europe Clinical Trial Site Management Organizations (SMOs) Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
  • Table 21 Germany Clinical Trial Site Management Organizations (SMOs) Market, by Services/ Components, 2018 - 2030 (USD Million)
  • Table 22 Germany Clinical Trial Site Management Organizations (SMOs) Market, by Phase, 2018 - 2030 (USD Million)
  • Table 23 Germany Clinical Trial Site Management Organizations (SMOs) Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
  • Table 24 UK Clinical Trial Site Management Organizations (SMOs) Market, by Services/ Components, 2018 - 2030 (USD Million)
  • Table 25 UK Clinical Trial Site Management Organizations (SMOs) Market, by Phase, 2018 - 2030 (USD Million)
  • Table 26 UK Clinical Trial Site Management Organizations (SMOs) Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
  • Table 27 France Clinical Trial Site Management Organizations (SMOs) Market, by Services/ Components, 2018 - 2030 (USD Million)
  • Table 28 France Clinical Trial Site Management Organizations (SMOs) Market, by Phase, 2018 - 2030 (USD Million)
  • Table 29 France Clinical Trial Site Management Organizations (SMOs) Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
  • Table 30 Italy Clinical Trial Site Management Organizations (SMOs) Market, by Services/ Components, 2018 - 2030 (USD Million)
  • Table 31 Italy Clinical Trial Site Management Organizations (SMOs) Market, by Phase, 2018 - 2030 (USD Million)
  • Table 32 Italy Clinical Trial Site Management Organizations (SMOs) Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
  • Table 33 Spain Clinical Trial Site Management Organizations (SMOs) Market, by Services/ Components, 2018 - 2030 (USD Million)
  • Table 34 Spain Clinical Trial Site Management Organizations (SMOs) Market, by Phase, 2018 - 2030 (USD Million)
  • Table 35 Spain Clinical Trial Site Management Organizations (SMOs) Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
  • Table 36 Denmark Clinical Trial Site Management Organizations (SMOs) Market, by Services/ Components, 2018 - 2030 (USD Million)
  • Table 37 Denmark Clinical Trial Site Management Organizations (SMOs) Market, by Phase, 2018 - 2030 (USD Million)
  • Table 38 Denmark Clinical Trial Site Management Organizations (SMOs) Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
  • Table 39 Sweden Clinical Trial Site Management Organizations (SMOs) Market, by Services/ Components, 2018 - 2030 (USD Million)
  • Table 40 Sweden Clinical Trial Site Management Organizations (SMOs) Market, by Phase, 2018 - 2030 (USD Million)
  • Table 41 Sweden Clinical Trial Site Management Organizations (SMOs) Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
  • Table 42 Norway Clinical Trial Site Management Organizations (SMOs) Market, by Services/ Components, 2018 - 2030 (USD Million)
  • Table 43 Norway Clinical Trial Site Management Organizations (SMOs) Market, by Phase, 2018 - 2030 (USD Million)
  • Table 44 Norway Clinical Trial Site Management Organizations (SMOs) Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
  • Table 45 Asia Pacific Clinical Trial Site Management Organizations (SMOs) Market, by Country, 2018 - 2030 (USD Million)
  • Table 46 Asia Pacific Clinical Trial Site Management Organizations (SMOs) Market, by Services/ Components, 2018 - 2030 (USD Million)
  • Table 47 Asia Pacific Clinical Trial Site Management Organizations (SMOs) Market, by Phase, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific Clinical Trial Site Management Organizations (SMOs) Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
  • Table 49 China Clinical Trial Site Management Organizations (SMOs) Market, by Services/ Components, 2018 - 2030 (USD Million)
  • Table 50 China Clinical Trial Site Management Organizations (SMOs) Market, by Phase, 2018 - 2030 (USD Million)
  • Table 51 China Clinical Trial Site Management Organizations (SMOs) Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
  • Table 52 Japan Clinical Trial Site Management Organizations (SMOs) Market, by Services/ Components, 2018 - 2030 (USD Million)
  • Table 53 Japan Clinical Trial Site Management Organizations (SMOs) Market, by Phase, 2018 - 2030 (USD Million)
  • Table 54 Japan Clinical Trial Site Management Organizations (SMOs) Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
  • Table 55 India Clinical Trial Site Management Organizations (SMOs) Market, by Services/ Components, 2018 - 2030 (USD Million)
  • Table 56 India Clinical Trial Site Management Organizations (SMOs) Market, by Phase, 2018 - 2030 (USD Million)
  • Table 57 India Clinical Trial Site Management Organizations (SMOs) Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
  • Table 58 South Korea Clinical Trial Site Management Organizations (SMOs) Market, by Services/ Components, 2018 - 2030 (USD Million)
  • Table 59 South Korea Clinical Trial Site Management Organizations (SMOs) Market, by Phase, 2018 - 2030 (USD Million)
  • Table 60 South Korea Clinical Trial Site Management Organizations (SMOs) Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
  • Table 61 Australia Clinical Trial Site Management Organizations (SMOs) Market, by Services/ Components, 2018 - 2030 (USD Million)
  • Table 62 Australia Clinical Trial Site Management Organizations (SMOs) Market, by Phase, 2018 - 2030 (USD Million)
  • Table 63 Australia Clinical Trial Site Management Organizations (SMOs) Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
  • Table 64 Thailand Clinical Trial Site Management Organizations (SMOs) Market, by Services/ Components, 2018 - 2030 (USD Million)
  • Table 65 Thailand Clinical Trial Site Management Organizations (SMOs) Market, by Phase, 2018 - 2030 (USD Million)
  • Table 66 Thailand Clinical Trial Site Management Organizations (SMOs) Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
  • Table 67 Latin America Clinical Trial Site Management Organizations (SMOs) Market, by Country, 2018 - 2030 (USD Million)
  • Table 68 Latin America Clinical Trial Site Management Organizations (SMOs) Market, by Services/ Components, 2018 - 2030 (USD Million)
  • Table 69 Latin America Clinical Trial Site Management Organizations (SMOs) Market, by Phase, 2018 - 2030 (USD Million)
  • Table 70 Latin America Clinical Trial Site Management Organizations (SMOs) Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
  • Table 71 Brazil Clinical Trial Site Management Organizations (SMOs) Market, by Services/ Components, 2018 - 2030 (USD Million)
  • Table 72 Brazil Clinical Trial Site Management Organizations (SMOs) Market, by Phase, 2018 - 2030 (USD Million)
  • Table 73 Brazil Clinical Trial Site Management Organizations (SMOs) Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
  • Table 74 Mexico Clinical Trial Site Management Organizations (SMOs) Market, by Services/ Components, 2018 - 2030 (USD Million)
  • Table 75 Mexico Clinical Trial Site Management Organizations (SMOs) Market, by Phase, 2018 - 2030 (USD Million)
  • Table 76 Mexico Clinical Trial Site Management Organizations (SMOs) Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
  • Table 77 Argentina Clinical Trial Site Management Organizations (SMOs) Market, by Services/ Components, 2018 - 2030 (USD Million)
  • Table 78 Argentina Clinical Trial Site Management Organizations (SMOs) Market, by Phase, 2018 - 2030 (USD Million)
  • Table 79 Argentina Clinical Trial Site Management Organizations (SMOs) Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
  • Table 80 Middle East & Africa Clinical Trial Site Management Organizations (SMOs) Market, by Country, 2018 - 2030 (USD Million)
  • Table 81 Middle East & Africa Clinical Trial Site Management Organizations (SMOs) Market, by Services/ Components, 2018 - 2030 (USD Million)
  • Table 82 Middle East & Africa Clinical Trial Site Management Organizations (SMOs) Market, by Phase, 2018 - 2030 (USD Million)
  • Table 83 Middle East & Africa Clinical Trial Site Management Organizations (SMOs) Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
  • Table 84 South Africa Clinical Trial Site Management Organizations (SMOs) Market, by Services/ Components, 2018 - 2030 (USD Million)
  • Table 85 South Africa Clinical Trial Site Management Organizations (SMOs) Market, by Phase, 2018 - 2030 (USD Million)
  • Table 86 South Africa Clinical Trial Site Management Organizations (SMOs) Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia Clinical Trial Site Management Organizations (SMOs) Market, by Services/ Components, 2018 - 2030 (USD Million)
  • Table 88 Saudi Arabia Clinical Trial Site Management Organizations (SMOs) Market, by Phase, 2018 - 2030 (USD Million)
  • Table 89 Saudi Arabia Clinical Trial Site Management Organizations (SMOs) Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
  • Table 90 UAE Clinical Trial Site Management Organizations (SMOs) Market, by Services/ Components, 2018 - 2030 (USD Million)
  • Table 91 UAE Clinical Trial Site Management Organizations (SMOs) Market, by Phase, 2018 - 2030 (USD Million)
  • Table 92 UAE Clinical Trial Site Management Organizations (SMOs) Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
  • Table 93 Kuwait Clinical Trial Site Management Organizations (SMOs) Market, by Services/ Components, 2018 - 2030 (USD Million)
  • Table 94 Kuwait Clinical Trial Site Management Organizations (SMOs) Market, by Phase, 2018 - 2030 (USD Million)
  • Table 95 Kuwait Clinical Trial Site Management Organizations (SMOs) Market, by Therapeutic Areas, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Information Procurement
  • Fig. 2 Primary Research Pattern
  • Fig. 3 Market Research Approaches
  • Fig. 4 Value Chain-Based Sizing & Forecasting
  • Fig. 5 Market Formulation & Validation
  • Fig. 6 Clinical Trial Site Management Organizations (SMOs) Market, Market Segmentation
  • Fig. 7 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 8 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 9 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 10 Porter's Five Forces Analysis
  • Fig. 11 Regional Marketplace: Key Takeaways
  • Fig. 12 Global Clinical Trial Site Management Organizations (SMOs) Market, for Phase I, 2018 - 2030 (USD Million)
  • Fig. 13 Global Clinical Trial Site Management Organizations (SMOs) Market, for Phase II, 2018 - 2030 (USD Million)
  • Fig. 14 Global Clinical Trial Site Management Organizations (SMOs) Market, for Phase III, 2018 - 2030 (USD Million)
  • Fig. 15 Global Clinical Trial Site Management Organizations (SMOs) Market, for Phase IV, 2018 - 2030 (USD Million)
  • Fig. 16 Global Clinical Trial Site Management Organizations (SMOs) Market, for Site Management, 2018 - 2030 (USD Million)
  • Fig. 17 Global Clinical Trial Site Management Organizations (SMOs) Market, for Project Management, 2018 - 2030 (USD Million)
  • Fig. 18 Global Clinical Trial Site Management Organizations (SMOs) Market, for Regulatory , 2018 - 2030 (USD Million)
  • Fig. 19 Global Clinical Trial Site Management Organizations (SMOs) Market, for Onsite Monitoring, 2018 - 2030 (USD Million)
  • Fig. 20 Global Clinical Trial Site Management Organizations (SMOs) Market, for Others , 2018 - 2030 (USD Million)
  • Fig. 21 Global Clinical Trial Site Management Organizations (SMOs) Market, for Oncology, 2018 - 2030 (USD Million)
  • Fig. 22 Global Clinical Trial Site Management Organizations (SMOs) Market, for Cardiology , 2018 - 2030 (USD Million)
  • Fig. 23 Global Clinical Trial Site Management Organizations (SMOs) Market, for CNS, 2018 - 2030 (USD Million)
  • Fig. 24 Global Clinical Trial Site Management Organizations (SMOs) Market, for Pain Management, 2018 - 2030 (USD Million)
  • Fig. 25 Global Clinical Trial Site Management Organizations (SMOs) Market, for Enodcrine, 2018 - 2030 (USD Million)
  • Fig. 26 Global Clinical Trial Site Management Organizations (SMOs) Market, for Others, 2018 - 2030 (USD Million)
  • Fig. 27 Regional Outlook, 2021 & 2030
  • Fig. 28 North America Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030 (USD Million)
  • Fig. 29 U.S. Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030 (USD Million)
  • Fig. 30 Canada Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030 (USD Million)
  • Fig. 31 Europe Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030 (USD Million)
  • Fig. 32 Germany Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030 (USD Million)
  • Fig. 33 UK Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030 (USD Million)
  • Fig. 34 France Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030 (USD Million)
  • Fig. 35 Italy Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030 (USD Million)
  • Fig. 36 Spain Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030 (USD Million)
  • Fig. 37 Asia Pacific Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030 (USD Million)
  • Fig. 38 Japan Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030 (USD Million)
  • Fig. 39 China Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030 (USD Million)
  • Fig. 40 India Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030 (USD Million)
  • Fig. 41 Australia Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030 (USD Million)
  • Fig. 42 South Korea Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030 (USD Million)
  • Fig. 43 Latin America Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030 (USD Million)
  • Fig. 44 Brazil Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030 (USD Million)
  • Fig. 45 Mexico Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030 (USD Million)
  • Fig. 46 Argentina Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030 (USD Million)
  • Fig. 47 Colombia Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030 (USD Million)
  • Fig. 48 Middle East and Africa Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030 (USD Million)
  • Fig. 49 South Africa Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030 (USD Million)
  • Fig. 50 Saudi Arabia Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030 (USD Million)
  • Fig. 51 UAE Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030 (USD Million)